Sun Pharma dividend: Drug major announces 400% payout
Sun Pharma dividend: Sun Pharmaceutical announced a final dividend of Rs 4 per equity share — a 400 per cent payout given the face value of Re 1 per share.
)
Sun Pharma dividend: Sun Pharmaceutical announced a final dividend of Rs 4 per equity share — a 400 per cent payout given the face value of Re 1 per share to its shareholders.
"Recommended Final Dividend for financial year 2022-23 Final dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re. l/- (Rupee One only) each of the Company is recommended subject to approval of the shareholders at the ensuing 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013," the drug major's filing said.
Sun Pharma dividend history
TRENDING NOW
Source: NSE
Sun Pharma Q4 results
Sun Pharma on May 26, Friday reported a consolidated profit of Rs 1,982.9 crore for the quarter ended March 2023 against a loss of Rs 2,227.38 crore in the year-ago period. Read more
Sun Pharma share price NSE, Sun Pharma share price history
Sun Pharma shares finished up 2.32 per cent or Rs 21.95 at Rs 966.95 apiece on NSE. Sun Pharma's stock has given a positive return of nearly 7 per cent in the last year (May 26, 2022). In comparison, the headline index Nifty 50 has rallied over 13 per cent.
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com
04:35 pm
Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise
Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease
Sun Pharma, Lupin recall drugs in US market: USFDA 
Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share
Sun Pharma inks licensing pact with Aclaris Therapeutics